
With a lawsuit, a House delay bill and drugmaker intervention motions in play, here's where HRSA's 340B rebate pilot stands ahead of Jan. 1.
Based on insights from over 360 life science professionals, this benchmark study examines how organizations across pharma, biotech, research, and healthcare are managing the storage and oversight of biological materials. The report reveals how leaders are balancing security, regulatory compliance, temperature control, and cost while maintaining the speed and reliability required for critical sample access.






